These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 22209230

  • 1. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies.
    Higa MM, Petersen J, Hooper J, Doms RW.
    Virology; 2012 Feb 20; 423(2):134-42. PubMed ID: 22209230
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
    Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C.
    Vaccine; 2008 Sep 19; 26(40):5177-81. PubMed ID: 18482782
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test.
    Hujakka H, Koistinen V, Kuronen I, Eerikäinen P, Parviainen M, Lundkvist A, Vaheri A, Vapalahti O, Närvänen A.
    J Virol Methods; 2003 Mar 19; 108(1):117-22. PubMed ID: 12565162
    [Abstract] [Full Text] [Related]

  • 5. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW, Josleyn M, Ballantyne J, Brocato R.
    Vaccine; 2013 Sep 13; 31(40):4314-21. PubMed ID: 23892100
    [Abstract] [Full Text] [Related]

  • 6. Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.
    Xiong HR, Li Q, Chen W, Liu DY, Ling JX, Liu J, Liu YJ, Zhang Y, Yang ZQ.
    Eur J Clin Microbiol Infect Dis; 2011 May 13; 30(5):645-51. PubMed ID: 21222012
    [Abstract] [Full Text] [Related]

  • 7. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
    Zhao C, Sun Y, Zhao Y, Wang S, Yu T, Du F, Yang XF, Luo E.
    Hum Vaccin Immunother; 2012 Feb 13; 8(2):208-15. PubMed ID: 22426376
    [Abstract] [Full Text] [Related]

  • 8. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
    Hooper JW, Custer DM, Thompson E, Schmaljohn CS.
    J Virol; 2001 Sep 13; 75(18):8469-77. PubMed ID: 11507192
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines for HFRS: laboratory and clinical studies.
    Schmaljohn CS, Spik KW, Hooper JW.
    Virus Res; 2014 Jul 17; 187():91-6. PubMed ID: 24370868
    [Abstract] [Full Text] [Related]

  • 10. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test.
    Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J.
    Clin Diagn Lab Immunol; 2003 Jan 17; 10(1):154-60. PubMed ID: 12522053
    [Abstract] [Full Text] [Related]

  • 11. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
    Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW.
    Vaccine; 2012 Mar 02; 30(11):1951-8. PubMed ID: 22248821
    [Abstract] [Full Text] [Related]

  • 12. Development of an immunochromatography strip test based on truncated nucleocapsid antigens of three representative hantaviruses.
    Amada T, Yoshimatsu K, Koma T, Shimizu K, Gamage CD, Shiokawa K, Nishio S, Ahlm C, Arikawa J.
    Virol J; 2014 May 14; 11():87. PubMed ID: 24885901
    [Abstract] [Full Text] [Related]

  • 13. Detection of Hantaan virus RNA from anti-Hantaan virus IgG seronegative rodents in an area of high endemicity in Republic of Korea.
    No JS, Kim WK, Kim JA, Lee SH, Lee SY, Kim JH, Kho JH, Lee D, Song DH, Gu SH, Jeong ST, Kim HC, Klein TA, Song JW.
    Microbiol Immunol; 2016 Apr 14; 60(4):268-71. PubMed ID: 26917012
    [Abstract] [Full Text] [Related]

  • 14. Viral load and humoral immune response in association with disease severity in Puumala hantavirus-infected patients--implications for treatment.
    Pettersson L, Thunberg T, Rocklöv J, Klingström J, Evander M, Ahlm C.
    Clin Microbiol Infect; 2014 Mar 14; 20(3):235-41. PubMed ID: 23742660
    [Abstract] [Full Text] [Related]

  • 15. Puumala and Tula Virus Differ in Replication Kinetics and Innate Immune Stimulation in Human Endothelial Cells and Macrophages.
    Bourquain D, Bodenstein C, Schürer S, Schaade L.
    Viruses; 2019 Sep 14; 11(9):. PubMed ID: 31540120
    [Abstract] [Full Text] [Related]

  • 16. Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.
    Liang M, Mahler M, Koch J, Ji Y, Li D, Schmaljohn C, Bautz EK.
    J Med Virol; 2003 Jan 14; 69(1):99-107. PubMed ID: 12436484
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
    Brocato RL, Josleyn MJ, Wahl-Jensen V, Schmaljohn CS, Hooper JW.
    Clin Vaccine Immunol; 2013 Feb 14; 20(2):218-26. PubMed ID: 23239797
    [Abstract] [Full Text] [Related]

  • 19. Orthohantaviruses belonging to three phylogroups all inhibit apoptosis in infected target cells.
    Solà-Riera C, Gupta S, Ljunggren HG, Klingström J.
    Sci Rep; 2019 Jan 29; 9(1):834. PubMed ID: 30696898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.